Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Schulze-Koops

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Zeitschrift Fur Rheumatologie|September 14, 2020
[Prevalence and treatment of rheumatological adverse events due to immune checkpoint inhibitor therapy]S H Verspohl, H Schulze-Koops, A Heine, et al.
Annals of the Rheumatic Diseases|March 16, 2007
Autosplenectomy: rare syndrome in autoimmunopathyJ Leipe, A J Hueber, S Kallert, et al.
Arthritis Research|February 15, 2001
Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cellsL S Davis, J J Cush, H Schulze-Koops, et al.
Clinical and Experimental Immunology|November 1, 1996
Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1)H Schulze-Koops, P E Lipsky, A F Kavanaugh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefitH Schulze-Koops, P E Lipsky, A F Kavanaugh, et al.
Zeitschrift Fur Rheumatologie|September 17, 2009
[Health-economic assessment of combination therapy for rheumatoid arthritis with methotrexat and etanercept based on the TEMPO Study]H Schulze-Koops, M Deeg, C Runge, et al.
Arthritis and Rheumatism|May 1, 1997
Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibodyA F Kavanaugh, H Schulze-Koops, L S Davis, et al.
Arthritis and Rheumatism|April 1, 1997
Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activationH Schulze-Koops, L S Davis, A F Kavanaugh, et al.
Arthritis and Rheumatism|October 20, 1998
Th1/Th2 cytokine balance in arthritis: comment on the article by Miossec and van den BergL S Davis, N Oppenheimer-Marks, H Schulze-Koops, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Altered memory T cell differentiation in patients with early rheumatoid arthritisA Skapenko, J Wendler, P E Lipsky, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Zeitschrift Fur Rheumatologie|September 14, 2020
[Prevalence and treatment of rheumatological adverse events due to immune checkpoint inhibitor therapy]S H Verspohl, H Schulze-Koops, A Heine, et al.
Annals of the Rheumatic Diseases|March 16, 2007
Autosplenectomy: rare syndrome in autoimmunopathyJ Leipe, A J Hueber, S Kallert, et al.
Arthritis Research|February 15, 2001
Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cellsL S Davis, J J Cush, H Schulze-Koops, et al.
Clinical and Experimental Immunology|November 1, 1996
Persistent reduction in IL-6 mRNA in peripheral blood mononuclear cells of patients with rheumatoid arthritis after treatment with a monoclonal antibody to CD54 (ICAM-1)H Schulze-Koops, P E Lipsky, A F Kavanaugh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 15, 1995
Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefitH Schulze-Koops, P E Lipsky, A F Kavanaugh, et al.
Zeitschrift Fur Rheumatologie|September 17, 2009
[Health-economic assessment of combination therapy for rheumatoid arthritis with methotrexat and etanercept based on the TEMPO Study]H Schulze-Koops, M Deeg, C Runge, et al.
Arthritis and Rheumatism|May 1, 1997
Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibodyA F Kavanaugh, H Schulze-Koops, L S Davis, et al.
Arthritis and Rheumatism|April 1, 1997
Elevated cytokine messenger RNA levels in the peripheral blood of patients with rheumatoid arthritis suggest different degrees of myeloid cell activationH Schulze-Koops, L S Davis, A F Kavanaugh, et al.
Arthritis and Rheumatism|October 20, 1998
Th1/Th2 cytokine balance in arthritis: comment on the article by Miossec and van den BergL S Davis, N Oppenheimer-Marks, H Schulze-Koops, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Altered memory T cell differentiation in patients with early rheumatoid arthritisA Skapenko, J Wendler, P E Lipsky, et al.
Pageof 11